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Abstract.  The disialogangliosides GD2 and GD3 play 
a major role in the ability of human melanoma cells to 
attach to Arg-Gly-Asp-containing  substrates such as 
fibronectin and vitronectin,  since pretreatment of these 
cells with monoclonal antibodies to the oligosaccha- 
ride of GD2 and GD3 can inhibit their attachment and 
spreading on such adhesive proteins.  This report 
demonstrates that human melanoma cells (M21)  syn- 
thesize and express a glycoprotein receptor that shares 
antigenic epitopes with the vitronectin receptor on hu- 
man fibroblasts and is capable of specifically recogniz- 
ing the Gly-Arg-Gly-Asp-Ser-Pro sequence. In the 
presence of calcium, GD2, the major ganglioside of 
M21  cells, colocalized with this receptor on the sur- 
face of human melanoma cells and their focal adhe- 
sion plaques as demonstrated by double-label transmis- 
sion immunoelectron microscopy and indirect immu- 
nofluorescence. Biochemical evidence is presented in- 
dicating that the vitronectin receptor on M21  human 
melanoma cells contains associated calcium and GD2. 
This ganglioside copurified with the glycoprotein 
receptor for vitronectin on affinity columns containing 
either an Arg-Gly-Asp-containing peptide, concanava- 
lin A, or lentil lectin.  This major Arg-Gly-Asp-di- 
rected receptor on M21  cells could be metabolically 
labeled with 45Ca2+. Chelation of this ion with EDTA 
caused the dissociation of GD2 from the receptor and 
rendered the remaining glycoprotein incapable of bind- 
ing to an Arg-Gly-Asp-containing peptide.  Reconstitu- 
tion experiments demonstrated a requirement for cal- 
cium, and not magnesium,  for receptor binding to 
Arg-Gly-Asp and indicated that addition of ganglioside 
can enhance this interaction. 
C 
ELL adhesion to the extracellular  matrix is a complex 
process involving the capacity of receptors on the cell 
surface to recognize and bind to a variety of adhesive 
matrix proteins.  A  class of divalent  cation-dependent  cell 
surface receptors has now been defined (5,  19, 21, 22) and 
shown to recognize  the sequence Arg-Gly-Asp  (RGD)  (37, 
43) found in a variety of adhesive proteins,  including  fibro- 
nectin (39, 40), vitronectin  (42), fibrinogen,  von Willebrand 
factor (24, 38, 41), and possibly laminin (26). The evolution- 
ary significance of RGD-dependent, cell-substratum interac- 
tions  is underscored by the fact that such interactions  have 
also been reported for slime mold (16, 48), and platelets (17, 
20, 40). In addition to the RGD receptors,  other molecular 
species on cell surfaces have been implicated in the capacity 
of cells to attach to extracellular  matrix proteins.  These in- 
clude proteoglycans (18, 31), and gangliosides  (10, 11, 28, 32, 
34, 36, 47, 53). In fact, gangliosides (i.e., sialic acid-con- 
taining glycolipids)  have been proposed to serve as the cell 
surface receptor for fibronectin  (28, 36, 53). This concept 
was based on the fact that exogenous addition ofgangliosides 
to cultured cells inhibited cell attachment  and spreading  on 
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a fibronectin  substrate.  The active moiety of such ganglio- 
sides was shown to reside in their oligosaccharide and partic- 
ularly their  sialic acid moiety,  since periodate oxidation  of 
terminal  sialic  acid destroyed the inhibitory  effects on cell 
attachment  (28). 
Studies from our laboratories have suggested that cell sur- 
face gangliosides  play a  major  role in  the attachment  of 
human  melanoma and neuroblastoma cells to various ex- 
tracellular  matrix components.  Thus, monoclonal antibodies 
(mAbs) to the oligosaccharide  portion of the disialoganglio- 
sides GD3 and GD2 ~  could specifically localize these mole- 
cules on the surface and in substrate-attached  focal adhesion 
plaques of human melanoma ceils (7,  10, 11). Pre- or post- 
treatment of these cells with anti-GD2 or anti-GD3 could in- 
hibit their attachment and spreading on a number of extracel- 
lular  matrix  proteins  including  fibronectin,  vitronectin, 
collagen,  laminin,  or  RGD-containing  synthetic  peptides 
(12), as well as an intact  matrix laid  down by bovine en- 
dothelial  cells (8). Periodate oxidation  of terminal  cell sur- 
face sialic acid on these cells resulted in a dose-dependent 
1. Gangliosides are termed according to the nomenclature of Svennerholm 
(50). 
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activity  of anti-ganglioside  rnAbs with the melanoma cell 
surface (12). An ultrastructural examination of the surface 
distribution of GD2 on M21 human melanoma cells revealed 
that this ganglioside was most heavily expressed on micro- 
processes emanating from the  surface  and making direct 
contact with a fibronectin substrate (10). Taken  together these 
data suggested the possibility that gangliosides on the surface 
of human melanoma cells may play a key role in cell attach- 
ment, either independently or in cooperation with cell sur- 
face RGD-receptors. 
This report presents direct ultrastructural and biochemical 
evidence that GD2 is part of a calcium-dependent functional 
complex, involving  the vitronectin receptor (VNr) 2 which 
is expressed on the surface of human melanoma cells. More- 
over, biochemical  data indicate that calcium is required for 
VNr recognition of RGD and that GD2,  although not re- 
quired,  augments receptor  function  in  the  presence  of 
calcium. 
Materials and Methods 
Cell Lines 
The M21 human melanoma cell line was kindly provided by Dr. D. L. Mor- 
ton (University of California, Los Angeles). These cells were propagated 
at 37~  in 7.5%  COd92.5% air in RPMI 1640, supplemented with 10% 
FCS and were shown to  be free  of mycoplasma by repeated testing during 
the course of these studies. GD2 was shown to be the predominant ganglio- 
side of M21 cells by intrinsic labeling with [3H]glucosamine  (11) and by 
quantitative surface staining using anti-GD2 mAb and flow cytometric anal- 
ysis (12). 
Monoclonal Antibodies 
The various sources of monoclonal antibodies used in these studies are 
listed with their isotype denoted in parentheses, mAbs 14.18 (IgG3) and 126 
(IgM) (10) are directed to the carbohydrate portion of ganglioside  GD2. 
mAb 9.2.27  (IgG2a) is directed to a 250-kD core glycoprotein  of a mela- 
noma-associated chondroitin sulfate proteoglycan (6) expressed on the sur- 
face of M21 human melanoma cells, mAb W6/32 (IgG2a) anti-HLA (human 
lymphocyte antigen) was the gift of Dr.  P. Parham (Stanford University). 
All IgG mAbs were isolated from murine asciles fluid and purified on a 
protein-A Sepharose (Pharmaeia, Inc., Piscataway, NJ) immunoadsorbant 
by a procedure described previously (35). mAb oflgM isotype was isolated 
from murine ascites as previously described (57). The antibodies directed 
to GD2 used in this study were previously  shown to be nonreactive with 
carbohydrate  determinants on glycoproteins  (10). 
Indirect Immunofluorescence 
M21 melanoma cells were allowed to attach for 60-90 rain to glass cover- 
slips previously  coated for 24 h with human vitronectin at 5-10 ~tg/ml in 
PBS pH 7.2. After the cells had attached and spread, they were permeabi- 
lized with 0.1% Triton X-100 for 5 rain at 40C and were fixed with 3% 
paraformaldehyde  for 15 rain  at room teanperature. Each coverslip was then 
individually washed several times in Hanks' balanced salt solution (I-IBSS) 
(Gibeo, Grand Island, NY), followed by an additional wash in HBSS con- 
taining 0.1 M glycine. The cells were then overlaid with an appropriate mu- 
fine mAb or affinity-purified polyclonal rabbit anti-VNr at a concentration 
of '~5 ~tg/ml for I h at room temperature.  After three washes in HBSS con- 
taining 1% BSA, the cells were overlaid with FITC-conjugated  goat anti- 
rabbit IgG (Boehringer Marmheim Biochemicals,  Indianapolis, IN) diluted 
1:1000 and/or rhodamine-conjugated goat anti-mouse IgG (Southern Bio- 
technology Associates, Inc., Birmingham, AL) diluted 1:800 for 1 h at room 
temperature.  After three additional washes, the coverslips were inverted and 
mounted on slides in a drop of Fluoromount-G (Fischer Scientific,  Pitts- 
burgh, PA). The stained cells were observed through a Zeiss epifluorescent 
microscopy  and photographed. 
2.  Abbreviations used in this paper:  HLA, human lymphocyte  antigen; 
VNr, vitronectin receptor; WGA, wheat germ agglutinin. 
Transmission Immunoelectron Microscopy 
M21 cells grown in suspension culture were washed free of growth media 
and resuspended in PBS containing 10 mM EDTA for 15 rain at room tem- 
parature. The cells were then washed, resuspended in HBSS with or without 
1 mM Ca  2+ and Mg  2+ for 15 min at 370C, and fixed for 30 rain at room 
temperature with 0.5% glntaraldehyde  in PBS. After a brief wash in HBSS 
containing 0.1 M glycine,  the appropriately  diluled murine monoclonal  or 
affinity-purified rabbit polyclonal antiserum was added to each dish for 3 h 
at room temperature.  After three washes,  each sample was overlayed with 
goat anti-mouse IgG (Cappel Laboratories, Inc., Cochranville, PA) and/or 
goat anti-rabbit IgG coupled to colloidal gold (27). Gold was prepared by 
using the ether (5-7 nm) or the Na-citrate (20-30 nm) reduction of anro- 
chloric acid methods (46). After conjugation, each preparation was cen- 
trifuged to remove aggregates and then tested for its ability to specifically 
stain the IgG band of immunoblotted  mouse or rabbit  serum after separation 
by SDS-PAGE. After incubation with gold-labeled  secondary antibody, the 
cells were washed three times and fixed with 2.5 % glutaraldehyde  in PBS, 
washed,  and postfixed in 1% OsO4. To increase contrast, thiocarbohydra- 
zide-osmium double fixation  was  performed.  Samples  were dehydrated 
using a graded series of ethanols from 50-100% and each dish was embed- 
ded in Epon 812, cured in vacuo for 48 h at 60~  (29), and sectioned on 
an ultrotome V (LKB Instruments, Inc., Gaithersburg, MD). Samples were 
viewed in an Hitachi H-600 STEM with a LaB6 or pointed filament. Trans- 
mission immunoelectron microscopy  was also performed on vitronectin- 
adherent M21 cells as previously described (10). 
Intrinsic Labeling and Indirect lmmunoprecipitation 
M21 human melanoma cells (107 cells in a 75-cm  2 flask) were labeled for 
24 h with 1 mCi of [3I-l]leucine fll0 mCilmmole; New England Nuclear, 
Cambridge,  MA) in leucine-free growth media.  Cell monolayers  were 
washed and extracted at 4~  with RIPA lysis buffer (6), which consisted of 
100 mM Tris-Cl, pH 7.2, 0.15 M NaCI, 1% (wt/vol) deoxycholate,  1% SDS, 
and 15 (wt/vol) trasylol (Sigma Chemical Co., St. Louis, MO). Cell lysates 
were cleared by ultracentrifugation  at 35,000 rpm in an ultracentrifuge (L3- 
50; SW 50.1 rotor; Beckman Instruments, Inc., P01o Alto) for 40 rain at 4~ 
and then were stored at -200C until use. Lysales were also prepared from 
focal adhesion plaques remaining on substrate after cell removal with EDTA 
as described (13). 
Affinity-purified  anti-VNr antibody or mAb was  adsorbed to protein 
A-Sepharose  directly and washed.  Immunoadsorbants, each consisting of 
100 gl of 10% antibody-coated  protein A-Sepharose  were incubated with 
cell or adhesion plaque lysates overnight at 4~  were washed five times in 
PBS containing 0.1% ovalbumin and 0.5 % Tween 20, then resuspended and 
boiled in Laemmli sample buffer (30). Samples were analyzed by SDS- 
PAGE and subjected to fluoroautography  as described previously  (6). 
Preparation of Vitronectin Receptor  from M21 Human 
Melanoma Cells 
VNr from M21 cells was purified by affinity chromatography  essentially as 
described (41, 42).  M21 cells were grown in suspension culture and har- 
vested by centrifugation at 400 g. A 4-ml packed cell pellet was combined 
with  1 mi of cells,  surface labeled with mI by lactoperoxidase  and ex- 
tracted with 5 ml of extraction buffer (PBS containing 1 mM CaCI2, with 
or without 1 mM MgCl2),  100 mM octyiglucoside,  and 3 mM phenyl- 
methylsulfonyl  fluoride)  for 15 min at 4~  after which the extract was 
cleared by centrifugation at 25,000 g for 30 rain. To isolate the VNr cell 
lysate was directly applied to a Gly-Arg-Gly-Asp-Ser-Pro-Cys-Sepharose 
column (bed volume,  5 ml) and allowed  to bind at 4oc overnight. The 
column was washed with 25 ml of  extraction buffer containing 50 mM octyl- 
glucoside and eluted with this buffer containing 1 mg/ml of Gly-Arg-Gly- 
Asp-Ser-Pro peptide.  Fractions (1.25 ml) were collected  after application 
of the elution buffer and 50 gtl of each fraction was analyzed by SDS-PAGE 
as previously  described (41, 42). 
Intrinsic Labeling of  M21 Vitronectin Receptor 
with 4JCa2§ 
M21 cells (1.5 x  10  s) grown in suspension culture were washed with PBS 
and resaspended in 10 ml of low Ca  z+ (0.02 raM) containing RPMI 1640 
supplemented with 0.043 mM of 4SCa  2+ (Spec.  Act.  17.29 mc/mg; DuPont 
Co., Wilmington, DE) and dialyzed FCS. The cells were incubated at 37~ 
in suspension for 3.5 h and then diluted in this same media to 60 ml and 
incubated for 12 h. After labeling, the cells were washed free of exogenous 
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scribed above. 
ELISA Analysis of Vitronectin Receptor Fractions 
for Gangliosides 
An aliquot (300 IJl) of each column fraction (above) was extensively dia- 
lyzed against 1 mM CaC12 and lyophilized. Each lyophilized fraction was 
resuspended in 200 txl of methanol and subjected to mild sonication in a 
water bath and extensively vortexed.  15  ~tl of the methanol solution was 
added to individual wells of a polyvinyl chloride 96-well microtiter plate 
and allowed to dry at room temperature for 2 h. Wells coated with the peak 
column fraction were shown to contain 1-2 I.tg of total protein. The wells 
were then coated for 2 h at 37~  with 150 ltl of PBS containing 5% BSA 
and 5 % normal goat serum. The presence of ganglioside was determined 
by ELISA using anti-GD2 mAb 14.18 as primary antibody and peroxidaso- 
conjugated goat-anti mouse Ig (Bio-Rad Laboratories, Richmond, CA) as 
secondary antibody as previously described (14). The vitroneetin ree.eptor 
was analyzed on these same mierotiter plates using specific afffinity-purified 
polyclonal rabbit antiserum to the receptor as primary antibody and diluted 
peroxidase-conjugated goat anti-rabbit Ig (Bio-Rnd Laboratories). 
Isolation of Wheat Germ  Agglutinin (WGA)- or 
Concanavalin A (Con A )-binding Proteins  from M21 
Melanoma Cells 
A 2 ml octylglucoside extract of M21 melanoma cells was prepared as de- 
scribed above, incubated overnight at 4"C with 2 ml of WGA-Sepharose or 
Con A-Sepharose (Pharmacia Fine Chemicals) and washed extensively with 
extraction buffer. Bound proteins were eluted with N-acetylglucosamine or 
~t-methyl-~marmoside (200 mM in extraction buffer) for WGA or Con A, 
respectively. The eluted material was analyzed by SDS-PAGE and the pres- 
ence of various glycoproteins that were specifically bound to the lectin ma- 
trix was demonstrated. For analysis of protein-associated gangliosides, the 
eluted  material  was  dialyzed against  1  mM  CaCI2,  lyophilized, recon- 
stituted in methanol, and assayed by ELISA as described above. 
Depletion of  Cations and GD2  from VNr on Lentil 
Lectin Sepharose 
~25I- or 45Ca2+-labeled VNr, isolated from M21 melanoma cells (10-50 ~tg) 
in 2 ml (50 raM) octylglucoside, was incubated for 2 h at room temperature 
with I ml of  lentil leetin Sepharose (Pharmacia Fine Chemicals) and washed 
extensively with extraction buffer.  Divalent cations were removed from the 
bound receptor by washing the column with 10 ml of 10 mM EDTA in ex- 
traction buffer. The receptor protein was eluted with r 
(200 mM in extraction buffer) and assayed for receptor by SDS-PAGE and 
ELISA and for GD2 ELISA as described above. 
Reconstitution of Vitronectin Receptor with Cations 
and~or GD2 and Other Lipids 
The VNr depleted of cations and GD2 as described above was reconstituted 
in extraction buffer with or without 1 mM Ca  2+, Mg  2+ and/or 5 ~tM gan- 
glioside or phospbolipid for 1 h at 37~  followed by 1 h at 4~  This mate- 
rial was then allowed to bind to GRGDSPK-Sepharose as described above 
and eluted with the soluble GRGDSP peptide. 
Results 
Immunoprecipitation of  the latronectin Receptor 
from M21 Human Melanoma Cells and their Focal 
Adhesion Plaques 
A polyclonal  antibody prepared against the VNr from human 
placenta (39)  identified a  protein  in detergent extracts of 
metabolically labeled  M21  cells  or  their  focal  adhesion 
plaques. As shown in Fig. 1 (lane 1), this antiserum recog- 
nizes two distinct polypeptides of 130 and 105 kD as deter- 
mined by SDS-PAGE analysis of immunoprecipitated deter- 
gent cell  lysates under  reducing conditions.  These  same 
polypeptides remained associated with the substrate in focal 
Figure L Immunopreeipitation of vitroneetin receptor from M21 
cells and their focal adhesion plaques. Detergent lysates prepared 
from [3Hlleucine-labeled  M21 melanoma cells (lanes I and 3) and 
their adhesion plaques 0aries 2 and 4) were subjected to immuno- 
precipitation using rabbit anti-receptor antiserum 0anes 1 and 2) 
or mAb 9.2.27 (lanes 3 and 4). Immunopreeipitates  were analyzed 
by SDS-PAGE  on 10% gels  under reducing conditions as described 
in Materials and Methods. 
adhesion plaques after the cells were removed by mild deter- 
gent treatment of monolayers (Fig. 1, lane 2). In contrast, a 
250-kD melanoma cell-associated antigen immunoprecipi- 
tated with mAb 9.2.27 (6) could only be detected in a cell 
lysate (Fig. 1, lane 3) and was not associated with the focal 
adhesion plaques (lane 4).  The anti-VNr antiserum bound 
functional receptors since it inhibited M21 cell attachment to 
immobilized vitronectin (data not shown). 
Colocalization of  GD2 with the Vitronectin Receptor 
on the Surface of  M21 Melanoma Cells 
The possibility that complexes between GD2 and VNr may 
exist on the surface of M21  melanoma cells was examined 
by both indirect immunofluorescence microscopy and trans- 
mission immunoeleetron microscopy. For this purpose, M21 
cells attached to substrate-coated coverslips were fixed and 
allowed to  react  with monoclonal murine  anti-GD2  and 
polyclonal rabbit anti-VNr antibodies, followed by species- 
specific secondary antibodies labeled with fiuorescein or 
rhodamine. As shown in Fig. 2, the respective staining pat- 
terns for VNr (A) and GD2 (B) were strikingly similar, indi- 
cating significant colocalization (arrows). Moreover, focal 
adhesion plaques that remained after cell removal indicated 
colocalization (arrows)  of  the receptor and GD2. In contrast, 
murine mAb 9.2.27,  which detects a  250-kD  chondroitin 
sulfate proteoglycan core glycoprotein on these same mela- 
noma cells (Fig. 2 D), failed to show an analogous staining 
pattern with the VNr (Fig, 2  C).  In addition, this 250-kD 
antigen could not be detected in focal adhesion plaques of 
these cells (U). 
Transmission immunoelectron microscopy also demon- 
strated colocalization between GD2 and VNr (Fig. 3).  The 
presence of GD2 (Fig. 3, D-F) and class I histocompatibility 
HLA-antigens (Fig.  3,  A-C)  is  indicated by a  secondary 
anti-mouse antiserum coupled to large gold particles where- 
as the VNr is identified by secondary anti-rabbit antiserum 
coupled to small gold particles (Fig.  3, A-F).  In controls 
(Fig. 3, A-C), HLA (smallarrow)  and the VNr (large  arrow) 
showed no apparent colocalization on either the apical (A and 
B) or basal (B and C) surface of the vitronectin-attached 
cells.  In  contrast,  colocalization between  GD2  and  VNr 
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tor  for vitronectin  and  GD2 
colocalizes on the cell surface 
and in focal adhesion plaques. 
M21 melanoma cells attached 
to  vitronectin-coated  cover- 
slips  were  subjected  to dou- 
ble-label immunofluorescence 
as described  in Materials and 
Methods.  The primary anti- 
bodies  included  rabbit  anti- 
vitronectin receptor (A-D) and 
the  murine  anti-GD2  mAb 
14.18 (A and B) or anti-chon- 
droitin  sulfate  proteoglycan, 
mAb 9.2.27 (C and D). Rho- 
damine-labeled anti-rabbit (A 
and C) and fluorescein-labeled 
anti-mouse  (B and  D)  were 
used  as  secondary  antibody. 
(Arrows) Areas of colocaliza- 
tion.  Bar, 25 I~m. 
(large arrowhead) was observed on both the basal and apical 
surfaces (Fig.  3,  D-F) as well as on a  cross section of a 
microprocess making direct contact with the vitronectin sub- 
strate (Fig.  3 E).  The small arrowheads (Fig.  3 E) depict 
noncolocalized GD2 that most probably resulted from this 
ganglioside's excess expression on the cell surface. 
Divalent Cation-dependent Colocalization of  GD2 
with the Vitronectin Receptor on the Surface of  M21 
Melanoma Cells 
The existence of divalent cation-dependent complexes be- 
tween GD2 and the VNr on the surface of M21  melanoma 
cells was investigated by indirect transmission immunoelec- 
tron microscopy. For this purpose, M21 cells grown in sus- 
pension  were exposed to  10  mM  EDTA,  reconstituted  in 
HBSS with or without 1 mM divalent cations, fixed, and al- 
lowed to react with monoclonal murine anti-GD2 antibody 
and rabbit anti-VNr antibody, followed by species-specific 
secondary  antibodies  labeled  with  gold  particles  distin- 
guished by their size. As shown in Fig. 4, in the absence of 
divalent cations (A, C, and E) neither HLA (A, short arrows) 
or  GD2  (C, E, small arrowheads) colocalized  with  VNr 
(long arrows). In contrast, in the presence of divalent cations 
(Fig. 4, B, D, and F) GD2 and VNr showed colocalization 
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M21 cells. M21 melanoma cells attached to vitroneetin-coated  microtiter wells were subjected  to double-label  transmission immunoeleetron 
microscopy as described in Materials and Methods. The primary antibodies included rabbit anti-vitronectin receptor (A and F) and murine 
mAb 14.18 (anti-GD2) (D--F) or mAb W6/32 (anti-HLA) (A-C).  Small  gold (7-9 rim) coupled to anti-rabbit Ig and large gold (20-30 
nm) coupled to anti-mouse Ig were used as secondary antibody.  Small  and large  arrows  correspond to the noncolocalized  HLA and receptor, 
respectively, whereas small and large arrowheads correspond to either free GD2 or GD2/receptor complexes, respectively.  Bars, 0.5 ~tm. 
(D, E  large arrowhead) whereas HLA and VNr did not (B, 
large and small arrows, respectively). The specificity of the 
colocalization is apparent since M21 cells stained with either 
anti-VNr antibody and an irrelevant mouse antibody or mAb 
14.18 used in conjuction with normal rabbit serum failed to 
show clustering of small and large gold particles (data not 
shown). 
To determine the relative percentage of colocalization of 
these antigens, quantitation of the gold particle distribution 
was performed on both adherent and suspension cells stained 
with antibodies directed to GD2 or HLA, and VNr as de- 
scribed in Figs. 3 and 4. As shown in Table I, 73  +  6% of 
the anti-VNr and anti-GD2 label is detected as colocalized, 
whereas only 16  +  3%  colocalization could be observed 
when adherent cells were stained with anti-VNr and anti- 
HLA (W6/32).  Similar results could be observed in cells 
grown in suspension. Antibodies directed to VNr and GD2 
showed 83  +  4% colocalization when cells were stained in 
the presence of calcium. However, cells that were stained in 
the absence of calcium only showed 21  +  8 % colocalized 
gold particles. 
Vitronectin Receptor lsolated  from M21 Cells Contains 
Ca  2§ and Disialoganglioside GD2 
To determine whether a functional VNr isolated from M21 
cells  contained associated Ca  2+ and GD2,  octylglucoside 
extracts of M21 cells that were surface labeled with ~2~I and 
metabolically labeled with 4sCa  2+ were subjected to affinity 
chromatography on GRGDSPK-Sepharose. Elution was with 
a buffer containing either GRGESP or GRGDSP and con- 
secutive fractions of the eluate were analyzed for radioactiv- 
ity or protein profile by SDS-PAGE autoradiography (Fig. 5 
inset) and GD2 by ELISA. As shown in Fig. 5, both the re'I- 
surface-labeled VNr  and 45Ca2+ appeared  as  sharp  peaks 
(fractions 4-7, right) that were only eluted from the column 
after GRGDSP was applied.  In addition, GD2 also eluted 
from this matrix, although slightly ahead of the peaks of ra- 
dioactivity (Fig. 5, fractions 3-7, right). In experiments with 
metabolically labeled 3H-GD2  and nonlabeled VNr,  inter- 
actions of the ganglioside with the peptide column were not 
observed unless receptor and cations were present (data not 
shown).  In addition,  neither receptor  nor GD2  could be 
eluted from this matrix in the presence of the control peptide 
GRGESP (Fig. 5, fractions 1-10, left). Thin layer chromatog- 
raphy results also confirmed the presence of intact GD2 in 
the VNr-enriched fractions and ruled out the possibility that 
this reactivity was due to the reaction of anti-GD2 mAb 
14.18 with a carbohydrate on this glycoprotein receptor (data 
not shown). 
To determine whether GD2 was present in other glycopro- 
tein fractions from M21 cells, octylglucoside extracts were 
subjected to affinity chromatography on the RGD peptide 
column,  WGA,  and Con A-Sepharose  and examined for 
GD2 content by ELISA. As shown in Fig. 6, the GD2 con- 
tent, determined by ELISA and expressed as OD 492 nm per 
gg of  protein, was •100-fotd  greater for material eluted from 
the peptide column than for several glycoproteins that specif- 
ically eluted from the WGA-Sepharose column (which does 
Cheresh et al. GD2 and Cations/Glycoprotein Adhesion Receptor  1167 Figure 4.  Divalent cation-dependent  colocalization of GD2 with the vitronectin receptor on the surface of M21 cells.  M21 cells grown 
in suspension culture were exposed to 10 mM EDTA in PBS, treated with HBSS in the absence (A, C, and E) or presence of 1 mM Ca  2+ 
and MG  2+ (B, D, and F) and fixed with 3 % paraformaldehyde. The cells were then allowed to react with murine mAb W6/32 (anti-HLA), 
(A and B) mAb 14.18 (anti-GD2) (C-F), and rabbit anti-VNr (A-F), washed, and stained with anti-rabbit Ig coupled to small gold (7-9 
nm) and anti-mouse Ig coupled to large gold (20-30 nm).  After further fixation, the cells were pelleted,  embedded,  and sections were 
cut and examined as described in Materials and Methods. (A and B) Short arrows  denote HLA, and long arrows denote VNr. (C-F) Long 
arrows denote free receptor, small arrowheads denote free GD2, and large arrowheads denote GD2/receptor  complexes. Bars, 0.5 Ixm. 
not bind this  receptor)  with the  monosaccharide N-acetyl 
glucosamine,  as  indicated  by Coornassie Blue  staining  of 
fractions separated by SDS-PAGE (data not shown).  How- 
ever, material eluted specifically from a  Con A-Sepharose 
column  contained  VNr  among other  proteins,  as  well  as 
some GD2. As shown in Fig. 6, GD2 was enriched ,,ol0-fold 
in fractions eluted from the RGD-containing affinity matrix 
when  compared  with  the  glycoproteins  eluted  from  Con 
A-Sepharose in the presence of a-methyl-o-mannoside. 
Divalent Cations and GD2 Are Functionally Involved 
in Arg-Gly-Asp Recosnition 
To ascertain whether divalent cations and/or GD2 were re- 
quired for Arg-Gly-Asp recognition, the VNr was isolated 
from M21  human melanoma cells by affinity chromatogra- 
phy on the RGD-containing peptide column, and the eluted 
receptor  was  allowed  to  bind  to  lentil  lectin  Sepharose, 
washed with 10 mM EDTA to remove associated divalent cat- 
ions, and then specifically eluted with u-methyl-D-manno- 
side. The elution profile of the lentil lectin Sepharose column 
appears in Fig.  7.  VNr isolated from M21  cells that were 
metabolically labeled with 45Ca2+ bound to the column and 
a peak of radioactivity could be eluted with 10 mM EDTA, 
demonstrating the  removal of a  major portion of the Ca  2+ 
from this receptor complex. A  significant amount of 45Ca2+ 
was also observed after elution with a-methyl-D-mannoside 
that suggests the possibility of another,  more tightly asso- 
Table L Colocalization of GD2 and VNr on the Surface of 
M21 Cells* 
Colocalized immunogold 
Cells  particles 
% 
Adherent 
GD2/VNr  73  +  6 
HLA/VNr  16 +  3 
Suspension 
GD2/VNr (+ Ca  2+)  83  +  4 
GD2/VNr (- Ca  2+)  21  +  8 
* Adherent or suspension grown M21 cells were stained with immunogold as 
described  in legends to Figs.  3 and 4, respectively.  Individual gold particles 
were counted and determined to be colocalized when large and small gold par- 
ticles were separated by less than the diameter of one large gold particle  (30 
nm). Each value is the mean •  SD of three to four determinations.  Each deter- 
mination represents the percentage of colocalized gold particles on 100 ~tm of 
linear  cell  membrane  from a  total  of 10-20  M21  cells  and  included  from 
200-1,500  individual particles. 
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raphy of the M21 human mel- 
anoma  vitroneetin  receptor 
complex.  M21  human  mela- 
noma cells  (10  s  )  were  either 
surface  labeled  with  t25I (o) 
or metabolically labeled with 
45CaC12 (0),  combined  with 
unlabeled  cells  (4-ml packed 
pellet),  and  extracted  as de- 
scribed in Materials and Meth- 
ods.  The  extract  was  chro- 
matographed  on a column of 
Sepharose  4B  (bed  volume 
5 ml) containing a covalently 
bomnl,  cell  attachment-pro- 
moting  peptide  GRGDSPK. 
The column was washed with 
5 ml of 50 mM octylglucoside 
followed by 50 ml of 25 mM 
octylthioglucoside  containing 
GRGDSP  (1  mg/ml),  after 
which the column was specif- 
ically eluted with the synthetic 
peptides GRGESP or GRGDSP 
(arrows) in 25 mM octylthio- 
glucoside.  Fractions  of  1.25 
ml  were  collected  and  cpm 
were determined in a beta or gamma counter of 50-ml aliquots of each fraction. Aliquots (15 gl) were analyzed by SDS-PAGE (10% acryl- 
amide) under reducing conditions and examined by autoradiography. The horizontal arrow marks the top of the separating gel. The relative 
GD2 (m) content  of each fraction  was determined  by ELISA using mAb  14.18 as a primary antibody  as described  in Materials  and 
Methods. 
ciated Ca2§  site not affected by 10 mM EDTA, al- 
though it is possible that some of the 45Ca2+ could have been 
eluted  from the  lentil  lectin itself.  In contrast,  VNr from 
~5I  surface-labeled  M21  cells  showed  a  minimal  elution 
peak of radioactivity in the presence of EDTA when sub- 
jected to the same lectin column chromatography. However, 
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Figure 6.  GD2 expression  in 
various M21 cell glycoprotein 
fractions.  Glycoprotein  frac- 
tions  from  M21  melanoma 
cells were prepared by affinity 
chromatography on Sepharose- 
coupled  matrices  containing 
GRGDSPK, Con A, or WGA, 
as described  in Materials and 
Methods. Eluted material (1 pg 
of  total  protein)  from  each 
column was adsorbed to indi- 
vidual  wells of a polystyrene 
microtiter  plate.  The relative 
GD2 content was determined 
by ELISA with mAb 14.18 as 
the primary antibody and ex- 
pressed  as the relative absor- 
bance at OD 492 above back- 
ground (i,e., in the absence of 
a reactive primary antibody). 
Each bar represents the mean 
of four replicates analyses. 
The possibility was examined that the association of GD2 
with the VNr complex is calcium dependent.  To this end, 
GD2 content  was determined by ELISA in  VNr-enriched 
fractions eluted from lentil lectin Sepharose. As shown in Ta- 
ble II, GD2 and VNr coeluted from this column only when 
it was washed with PBS containing 1 mM CaCI2. However, 
GD2 was completely eliminated from the complex when it 
was subjected to elution with 10 mM EDTA, yet this treat- 
ment had a  minimal effect on the quantity of receptor de- 
tected with the anti-VNr antibody. In addition, each of these 
VNr-enriched fractions were examined by SDS-PAGE and 
shown to be identical to the material isolated originally (Fig. 
1) since it contained both the 130 and 105-kD subunits (data 
not shown). 
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Figure 7. Lentil lectin affinity chromatography of vitronectin recep- 
tor complex.  Vitronectin  receptor,  radiolabeled  with  ~25I (e) or 
45Ca2§ (o), obtained as above, was chromatographed  on a lentil 
lectin Sepharose column (bed volume 1 rnl). Fractions  (0.25 ml) 
were collected during elution in octylglucoside containing either 10 
mM EDTA (arrow 1) or 200 mM a-methyl-~mannoside (arrow 
2) and the cpm of  each fraction were determined in a beta or gamma 
counter. 
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Vitronectin Receptor Complex 
Reactivity (OD 492) after elution from 
lentil lectin Sepharose* 
Antibody  1 mM CaC12  10 mM EDTA 
Anfi-VNr  2.114,  1.782 
14.18 (anti-GD2)  0.495  0.006 
W6/32 (anti-HLA)  0.002  0.004 
* Vitronectin receptor complex was allowed m bind to lentil lectin Sepharose, 
washed with PBS containing either 1 raM CaCl2 or 10 mbt EDTA, and then 
eluted with 200 mM ~t-methyl-v-mannoside as described in Materials and 
Methods. Antigenic reactivity was tested by ELISA using various primary anti- 
bodies. 
Average of duplicates. 
The functional requirement of VNr for divalent cations 
was assessed by determining the capacity of the receptor de- 
void of cations and GD2 to attach to the GRGDSPK-matrix 
in comparison with that of the intact receptor complex. As 
shown in Fig. 8, the intact receptor complex actively bound 
to the adhesion matrix, since 70% of the total radiolabeled 
material bound and could be specifically eluted with a solu- 
ble RGD-containing peptide (Fig. 8, fractions 10--16). Tiffs 
70% binding activity represents the total receptor activity 
that can be recovered from the GRGDSPK-Sepharose affin- 
ity matrix in the presence of soluble peptide. In contrast, 
after depletion of divalent cations and GD2, >80% of VNr 
appeared in the flow through and column wash with only 
19% eluting with soluble RGD.  However, there was some 
weak interaction of the adhesion matrix with the calcium- 
depleted receptor, since it was  somewhat retarded by the 
column appearing as a rather broad peak comprised by frac- 
tions 1-9 (Fig. 8). 
The divalent cation requirement for VNr receptor recogni- 
tion of RGD could also be demonstrated by the capacity of 
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Figure 8. Effects of divalent cation removal on vitronectin receptor 
function.  Vitroneetin receptor  isolated  from uSI-surface-labeled 
M21 cells was initially allowed to bind to lentil leetin Sepharose and 
then treated with either EDTA in PBS to deplete the receptor of 
divalent cations and ganglioside or PBS containing  1 mM Ca  2+ 
and  Mg  2+.  Elution  followed with  a-mathyl-D-mannoside. The 
receptor-containing fraction (15,000 epm) was then rechromato- 
graphed on a column of  GRGDSPK-Sepharose  4B (bed volume 1.2 
ml). Radioactivity in the vitronectin-enriched fractions (0.25 ml) 
treated with EDTA (a) or without EDTA (o) were determined in 
a gamma counter. Fractions 1-9 contain flow through. The specifi- 
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Figure 9. M21 vitronectin recep- 
tor function  after reconstitution 
with Ca  2+ and/or GD2. Vitronec- 
tin receptor isolated from mI-sur- 
face-labeled M21 cells was sub- 
jccted to lentil lectin affinity  chro- 
matography, treated with EDTA, 
and eluted with a-methyl-o-man- 
noside. The eluted receptor gly- 
coprotein in I ml of  50 mM octyl- 
glucoside was reconstituted with 
either  5  ktM GD2  (B),  1 mM 
Ca  2+ and Mg  2+ (C), both (D), or 
neither of the above (A) for 1 h at 
37~  followed by 1 h at 4~  Each reconstituted fraction was then 
allowed to bind to a GRGDSPK-Sepharose  column (1.2 ml bed vol- 
ume) and specific RGD-binding material was eluted with 1 mg/ml 
GRGDSP. Fractions (0.25 ml) were collected after the addition of 
the peptide solution (arrow) and the cpm of  each fraction was deter- 
mined in a gamma counter. The total cpm of receptor eluted with 
RGD was compared with the total material eluted before removal 
of  cations or GD2 (control) and each bar represents the RGD-eluted 
material after reconstitution as a percent of control and is the mean 
+  SEM of three separate experiments. 
EDTA (5 raM) to completely elute the receptor from the 
RGD-aflinity matrix (data not shown). 
Reconstitution of Vitronectin  Receptor Function in the 
Presence of  Divalent Cations and GD2 and other Lipids 
Reconstitution experiments were performed to determine the 
functional significance of divalent cations and GD2 in the 
VNr adhesion complex. Thus, VNr was depleted of  divalent 
cations and GD2 by EDTA treatment (as above) and then 
reconstituted  with  either  divalent  cations  (Ca  2+  and/or 
Mg  e+, 1 raM), gangliosides or phospholipid (5 gM), both, 
or neither of these components. Each reconstituted receptor 
was allowed to bind to the GRGDSPK-Sepharose column 
and was then subjected to elution with the soluble RGD- 
containing peptide. As shown in Fig. 9, the mean of three 
separate experiments demonstrated that little or no receptor 
activity could be demonstrated in the absence of  divalent cat- 
ions and GD2. The addition of GD2 in the absence of  cations 
also provided minimal receptor function (30 +  3 % SEM), 
whereas addition of  divalent cations alone resulted in moder- 
ate receptor function (75  +  6% SEM). However, complete 
recovery of receptor activity (99 +  2 % SEM) was observed 
only when GD2 was added together with divalent cations. 
These results indicate that VNr has a functional requirement 
for divalent cations and that the presence of GD2 serves to 
augment its function. 
To determine whether components other than GD2 and 
calcium can augment VNr receptor activity, reconstitution 
experiments were performed in the presence of Mg  2§  other 
gangliosides,  and phospholipids.  Mg  2§  unlike Ca  2§  was 
incapable of  restoring receptor activity in the presence or ab- 
sence of ganglioside indicating that the cation requirement 
of VNr is  somewhat restricted.  In the presence of Ca  2+, 
gangliosides other than GD2 had some receptor-augmenting 
activity relative to receptor reconstituted with cations alone. 
The gangliosides examined in these experiments were GM3, 
GM1, GDla, and GT1, which in the presence of Ca  2§ were 
shown to augment VNr binding to RGD by 20--40% over that 
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or phosphatidylserine  had no significant stimulatory effect 
on receptor activity, suggesting that the oligosaccharide por- 
tion of the ganglioside may be required for augmenting re- 
ceptor function. In addition, thin layer chromatography anal- 
ysis of VNr-containing fractions demonstrated the preserve 
of GD3 as well as GD2 (data not shown). Taken together, 
these data suggest that a number of  gangliosides have the ca- 
pacity to interact with the M21 cell VNr. 
Discussion 
The role of gangliosides in cell adhesion has been under in- 
vestigation since initial reports  suggested that their exoge- 
nous addition to cultured cells inhibits cell attachment (28, 
36, 53). These same studies implied that gangliosides could 
serve as receptors for adhesive substrates such as fibronec- 
tin. However, recent observations implicate a number of cell 
surface glycoproteins as receptors  for extracellular  matrix 
adhesive proteins (43). Based on these observations, reevalu- 
ation of the role of gangliosides in the cell attachment pro- 
cess has been necessary. For example, it seemed possible 
that gangliosides being anionic, might provide a more gener- 
alized  electrostatic  attraction  between cells  and  substrate. 
Gangliosides may also interact with an independent site on 
the substrate adhesive protein  (47, 52).  Alternatively, gan- 
gliosides may serve to modulate or potentiate the activity of 
specific cell surface glycoprotein receptors that are capable 
of interacting with a given substrate. The data presented in 
this report support this latter hypothesis by providing direct 
biochemical,  immunochemical,  ultrastructural,  and func- 
tional evidence that the disialoganglioside GD2 on the sur- 
face of human melanoma cells forms a calcium-dependent 
complex with a glycoprotein membrane receptor for vitro- 
nectin. 
The M21 human melanoma cells used in this study serve 
as an ideal model system to investigate the role of ganglio- 
sides in cell attachment for the following reasons. First, a 
monoclonal antibody (mAb 14.18) is available for the analy- 
sis of  GD2 (10), the major ganglioside of  M21 cells (U). This 
monoclonal antibody partially  inhibits the binding of M21 
cells to a number of RGD-containing  substrates (8).  Sec- 
ondly,  these  cells  attach  to  fibronectin,  vitronectin,  and 
RGD-peptide substrates (8). As demonstrated here, one of 
the receptors mediating such attachment has properties simi- 
lar to a vitronectin receptor described in other types of cells 
(40, 49). The vitronectin receptor expressed by the M21 ceils 
is composed of two polypeptides of 130 and 105 kD that as- 
sociate  posttranslationally  in  a  noncovalent  manner  and 
share  some  structural  and  antigenic  properties  with  the 
IIb/IIIa glycoprotein adhesion receptor on platelets (9). We 
chose this receptor for our study because it is abundant in 
the M21 cells and can be readily isolated (9) using affinity 
chromatography on RGD-containing peptides (42). 
The first indication of the complexing between GD2 and 
the vitronectin receptor was their colocalization at the cell 
surface and in adhesion plaques as demonstrated by immu- 
nofluorescence  and immunoelectron  microscopic  analysis 
with specific antibodies. The presence of  the ganglioside and 
the receptor in focal adhesion plaques suggests that they are 
specifically involved in the adhesion of  the M21 cells. In con- 
trast to the receptor, another melanoma-associated glycopro- 
tein, i.e., a chondroitin sulfate proteoglycan, was not found 
in the focal adhesions by SDS-PAGE analysis or by direct im- 
munofluorescence (U). 
The colocalization of GD2 with the vitronectin receptor 
was dependent on divalent cations and could be shown to be 
specific for the receptor. Immunoelectron microscopy indi- 
cated that the vitronectin  receptor  on the surface of M21 
melanoma cells was associated with GD2 only in the pres- 
ence of calcium. In contrast, in cells that were treated with 
EDNA, the receptor and GD2 immune reactivities were dis- 
tributed independently of  one another. The specificity of  the 
GD2-vitronectin receptor colocalization was apparent since 
an anti-HLA antibody, which also binds to the surface of 
M21 cells, did not significantly localize with the vitronectin 
receptor  under any circumstances.  Other controls  showed 
that the colocalization of  GD2 with the receptor was not due 
to cross-reactivity of any of the antibodies. 
The colocalization studies suggested that the vitronectin 
receptor and at least some of the cell surface GD2 exist as 
a complex at the cell surface and that the association between 
these two molecules is dependent on divalent cations. That 
this is the case is supported by direct biochemical evidence 
for the presence of  such a complex. The complexing between 
the vitronectin receptor and GD2 was evident from the pres- 
ence of GD2 in GRGDSPK-Sepharose affinity matrix frac- 
tions containing the vitronectin receptor, as detected by re- 
action  with  the  anti-GD2  mAb  14.18 and  by  thin layer 
chromatography. GD2 was enriched  100-fold  in such recep- 
tor fractions isolated from M21 cell extracts compared with 
GD2 in glycoprotein fractions obtained from similar extracts 
by chromatography on WGA. In fractions eluted from Con 
A columns, the enrichment  of GD2 was only 10-fold on a 
ganglioside to protein basis when compared with the isolated 
receptor fractions reflecting the fact that, although the M21 
vitronectin receptor binds to Con A, it is present in the Con 
A-bound fraction along with other glycoproteins. These data 
indicate  a  molecular  interaction  between  GD2  and  the 
vitronectin glycoprotein receptor. It is interesting to note that 
this receptor complex was isolated from cells that had grown 
for several days in suspension culture,  indicating  that the 
formation of such a complex did not depend on active cell- 
substratum interactions. 
It is likely that gangliosides other than GD2 can associate 
with the VNr. In this regard, thin layer chromatography anal- 
ysis of RGD-eluted VNr fractions revealed the presence of 
GD3 in addition to GD2 (data not shown). The fact that GD2 
and GD3 are the major gangliosides of M21 cells and both 
associate with the VNr suggests the possibility that ganglio- 
sides on other cell types show similar associations. 
Additional biochemical studies demonstrated that the vi- 
tronectin  receptor-GD2  complex  expressed  on M21  cells 
binds Ca  2+ and that binding of the divalent cation is neces- 
sary for the existence of the complex. We found that after 
these cells had been intrinsically  labeled  with 45Ca2+, the 
radiolabel coeluted with the receptor from the GRGDSPK- 
Sepharose affinity matrix. GD2 also copurified with the vi- 
tronectin  receptor  although,  upon elution of the adhesion 
matrix with soluble RGD-peptide, the ganglioside typically 
eluted slightly ahead of  the receptor. We attribute this to dis- 
sociation of  the receptor-ganglioside  complex upon elution. 
The elution of  the ganglioside ahead of  the receptor is consis- 
tent with the results reported by Heath et al. (25), demon- 
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rose  column  together  with  rabbit  immunoglobulin,  they 
eluted just before the protein.  These authors attributed the 
differences  to  the  formation  of ganglioside  micelles  that 
would elute rapidly  due to their  large  size.  Additionally, 
retardation of the receptor may occur because of the compe- 
tition of the matrix and the eluting peptide for the receptor. 
Regardless of the slight difference in the elution profiles of 
the receptor and GD2, their elution by the GRGDSP peptide 
was clearly specific, since a control peptide failed to elute ei- 
ther molecule. 
To  investigate  the  role  of divalent  cations  within  the 
vitronectin receptor GD2 complex, we removed the divalent 
cation from the receptor bound to lentil lectin Sepharose by 
washing with EDTA. The receptor eluted from such a col- 
urun was found to have lost most of its ability to bind to the 
GRGDSPK-Sepharose matrix. An analysis of the GD2 con- 
tent of the vitronectin  receptor depleted of cations in this 
manner showed that GD2 was also lost. Reconstitution of the 
receptor with calcium and a variety of gangliosides demon- 
strated that a significant part of the receptor activity could 
be regained simply by addition of calcium (75 % of original 
RGD-binding  activity) whereas Mg  2+ alone had no effect. 
However, receptor activity was increased when exogenous 
ganglioside was added together with the calcium, while the 
ganglioside alone failed to promote significant activity. Phos- 
pholipid could not substitute for the effects of ganglioside, 
suggesting that the potentiation effect by gangliosides may in- 
volve their oligosaccharide moiety. These results suggest that 
calcium and not magnesium is required for receptor activity, 
and  that  gangliosides  can  serve to  optimize  this  activity. 
However, at present we cannot rule out the possibility other 
divalent cations can substitute for Ca  2+. Recent primary se- 
quence analysis of the alpha chain of the human VNr has, 
in fact, revealed multiple calcium-binding sites (Suzuki, S., 
S.  Argraves,  H. Arai,  L. Lnnguino,  M.  D.  Pierschbacher, 
and  E.  Ruoslahti,  manuscript  submitted  for publication), 
suggesting a possible site on the protein involved in complex 
formation. Based on initial reconstitution experiments, gan- 
gliosides other than GD2 could potentiate receptor activity. 
VNr reconstituted with Ca  2+ and either GM3, GMI, GDla, 
or GT1, showed between 20-40%  increased receptor activ- 
ity. Additional experiments are required, however, to deter- 
mine whether a particular gangiioside has an optimal effect. 
Our result may aid in explaining the previous observation 
that monoclonai antibodies directed to GD2 or GD3 could 
partially inhibit M21 melanoma cell attachment to immobi- 
lized vitronectin  or the synthetic peptide GRGDSPC (12). 
Since our results show that the vitronectin receptor is com- 
plexed with GD2 at the cell surface, the anti-ganglioside an- 
tibody may stericaily inhibit the binding of the receptor to 
its ligand. Alternatively, the antibody could interfere with the 
potentiating activity of the ganglioside on the receptor func- 
tion. Our results also shed light on the findings of several in- 
vestigators (28, 36, 53) who have reported that exogenous ad- 
dition of gangliosides to cultured cells caused a loss of their 
attachment  to  a  fibronectin  substrate.  These  investigators 
suggested that gangliosides may serve as the actual cellular 
adhesion receptors. However, since the fibronectin and vitro- 
nectin receptors are related proteins (43, 49), and since anti- 
GD2 also inhibit the attachment of M21 cells to fibronectin 
substrate (12),  the fibronectin receptor is probably also as- 
sociated with gangliosides. That exogenous ganglioside ad- 
dition could inhibit cell attachment may be explained by an 
electrostatic perturbation of the functional receptor-ganglio- 
side complex on the cell surface or by an actual chelation of 
the divalent cations from the membrane receptors. 
The possibility that gangliosides on the cell surface may 
interact and modulate receptor function without acting di- 
rectly as receptors has also been suggested for other recep- 
tors. Such receptors include the platelet-derived growth fac- 
tor (3) and epidermal growth factor (4) receptors. 
The role of the ganglioside in the adhesion receptor com- 
plexes may be to orient the divalent cation required for the 
receptor to bind to its ligand.  This hypothesis is supported 
by the fact that gangliosides are known to interact with diva- 
lent cations through their terminal sialic acid residues (1, 2). 
In fact, (45) demonstrated that physiological levels of Ca  2+ 
led to  cross-linking  and  condensing  of ganglioside  head- 
groups  in  model membranes  through  complexing  of ear- 
boxyl groups of sialic acid. It is possible that in the presence 
of divalent  cations,  laterally  mobile carbohydrate-bearing 
components such as gangliosides may show a tendency to 
cluster about glycoproteins containing  one or several car- 
boxyl groups. Thus, depending on their ganglioside compo- 
sition,  cells with identical  RGD-dependent receptors may 
vary in their affinity for a given substrate, thereby allowing 
firm attachment of certain cells or migration and invasion as 
observed for embryonic and metastatic cells (33).  This hy- 
pothesis may also help to explain the observed variation in 
ganglioside composition associated with cellular differentia- 
tion (15, 23) and oncogenic transformation (7, 13, 14, 22, 44). 
It is clear that our results suggest that cell-substratum inter- 
actions involve a process whereby individual receptors func- 
tion  within an  asymmetric domain of the  lipid bilayer as 
receptor complexes containing  glycoproteins, divalent cat- 
ions, and gangliosides. 
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Note Added in Proof. Tile receptor termed VNr in this study has been shown 
to also re.c~gnize  fibrinogen and von W'fllebrand  factor and is expressed on 
human endothelial cell (Cheresh, D. A., 1987, Proc. Natl. Acad. Sci.  USA, 
In press).  Human  endothelial  cells  synthesize and  express  an Arg-Gly- 
Asp-directed adhesion receptor involved in attachment to fibrinogen and 
von Willebrand factor. 
R~r~/lce$ 
1. Abramson, M. B., Yu, R. K., and V. Zaby. 1972. Ionic properties of  beef 
brain gangliosides. Biochem.  Biophys.  Acta. 280:365-372. 
2. Behr, J. P., and J. M. l,elm. 1973. The binding of  cations by purified gan- 
gliosides. FEBS (Fed. Fur.  Biochera. Soc.).  Lett.  31:297-300. 
3. Bremer, E. G., S. Hakomori, D. F. Bowen-Pope,  E. Raines, and R. Ross. 
1984. Ganglioside-mediated  modulation of cell growth, growth factor 
The Journal of Cell Biology, Volume 105, 1987  1172 binding and receptor phosphorylation. J. Biol.  Chem.  259:6818-6825. 
4. Bremer, E.  G., L  Schlessinger, and S.  Hakomori.  1986.  Ganglioside- 
mediated modulation of cell growth. J. Biol.  Chem.  261:2434--2440. 
5. Brown, P. J., and R. L. Juliano. 1985.  Selective inhibition of fibronectin- 
mediated cell adhesion by monoclonal antibodies to a cell-surface glyco- 
protein. Science (Wash.  DC). 228:1448-1450. 
6. Bumol, T. F., and R. A. Reisfeld. 1982. Unique glyeoprotein-proteoglycan 
complex defined by a moneclonal on human melanoma  cells. Proc. Natl. 
Acad.  Sci.  USA.  79:1245-1249. 
7. Cheresh, D. A.  1985.  Structural and functional properties of ganglioside 
antigens on  human tumors of neuroectndermal origin.  Surv.  Synth. 
Pathol. Res. 4:97-109. 
8. D. A. Cheresh. 1987.  Ganglioside involvement in tumor cell-substratum 
interactions. In Induction and Recognition of  the Transformed cell. M. I. 
Greene and T. Hamaoka, editors. Plenum Publishing Corp., New York. 
In press. 
9. Cheresh, D. A., and J. R. Harper. 1987. Arg-Gly-Asp  recognition by a cell 
adhesion receptor requires its 130 kDa alpha subunit. J.  Biol.  Chem. 
262:1434-1437. 
10. Cheresh, D. A., and F. G. Klier. 1986. Disialoganglioside  GD2 distributes 
preferentially into substrate-associated microprocesses on human mela- 
noma cells during their attachment to fibronectin.  J.  Cell Biol.  102: 
1887-1897. 
11. Cheresh, D. A., J. R. Harper, G. Schnlz, and R, A. Reisfeld. 1984. Local- 
ization of the gangliosides GD2 and GD3 in adhesion plaques and on the 
surface of human melanoma cells.  Proc.  Natl.  Acad.  Sci.  USA.  81: 
5767-5771. 
12. Cheresh, D. A., M. D. Pierschbacher, M. A, Herzig, andK. Mujon. 1986. 
Disialogangliosides GD2 and GD3 are involved in the attachment of hu- 
man melanoma and neuroblastoma cells to extracellular matrix proteins. 
J.  Cell Biol.  102:688-696. 
13. Cheresh, D. A., R. A. Reisfeld, and A. P. Varki.  1984. O-acetylation of 
disialoganglioside GD3 by human melanoma cells creates a unique anti- 
genie determinant. Science (Wash. DC). 225:844-846. 
14. Cheresh, D. A., A. P. Varki, N. M. Varki, W. B. Stalleup,  1. Levine, and 
R. A. Reisfeld. 1984. A monoclonal antibody recognizes an O-acylated 
sialic acid in a human melanoma-associated  ganglioside. J. Biol.  Chem. 
259:7453-7459. 
15. Feizi, T. 1985. Demonstration by monoclonal antibodies that carbohydrate 
structures of glycoproteins and glycolipids are oncodevelopmental anti- 
gens. Nature (Lond.).  314:53-57. 
16. Gabius, H.-J., W. R. Springer, and S. H. Barondes. 1985.  Receptor for 
the cell binding site of discoidin 1.  Cell.  42:449-456. 
17. Gardner, J. M., and R. O. Hynes. 1985. Interaction of fibronectin with its 
receptor on platelets. Cell.  42:439--,148, 
18. Garner, J. A., and L. A. Culp.  1981.  Aggregration competence of pro- 
teoglyeans from substratum adhesion sites of routine fibroblasts. Bio- 
chemistry. 20:7350-7359. 
19. Gianeotti,  F.  G.,  G.  Tarone,  K.  Knudsen, C.  Damsky,  and  P.  M. 
Comoglio. 1985. Cleavage of a 135 KD cell surface glycoprotein corre- 
lates with loss of fibroblast adhesion to fibronectin. Exp.  Cell ges.  156: 
182-190. 
20. Ginsberg, M. H., M. D. Pierschbaeher, E. Ruostahti, G. Marguerie, and 
E. Plow. 1985. Inhibition of fibronectin binding to platelets by proteolytic 
fragments and synthetic peptides which support fibroblast adhesion. J. 
Biol.  Chem.  260:3931-3936. 
2t. Greve, J. M., and D. I. Gottlieb. 1982. Monoclonal antibodies which alter 
the morphology of cultured chick myogenic cells. J.  Cell Biochem. 
18:227-237. 
22. Hakomori, S. 1984. Tumor-associated carbohydrate antigens. Annu. Rev. 
Immunol.  2:103-126. 
23, Hakomori,  S.,  and  K.  Kannagi.  1983.  Glycosphingolipids as  tumor- 
associated and differentiation antigens. J, Natl.  Cancer Inst. 71:231-251. 
24. Haverstick, D. M., J. F. Cowan, K. M. Yamada, and S. A. Santoro. 1985. 
Inhibition  of platelet  adhesion  to  fibronectin,  fibrinogen,  and  von- 
Willebrand factor substrates by a synthetic tetrapeptide derived from the 
cell binding domain of fibronectin. B/ood.  66:946-956. 
25. Heath,  T.  D.,  F. J.  Martin,  and B.  A.  Maeher.  1983.  Association of 
ganglioside-protein conjugates into ceil and sendai virus. Exp. Cell Res. 
149:163-175. 
26. Horwitz, A., K. Duggan, R. Greggs, C. Decker, and C. Buck. 1985. The 
cell substrate attachment (CSAT) antigen has properties of a receptor for 
laminin and fibronectin.  J.  Cell Biol.  101:2134-2144. 
27. Jemn~rson, R., F. G. Klier, and W. H. Fishman. 1985. Clustered distribu- 
tion of human placental alkaline phosphatase on the surface of both 
placental and cancer cells: electron microscopic observations using gold- 
labeled antibodies. J.  Histochem.  Cytochem.  33:1227-1234. 
28. Kleinman, H. K., G. R. Martin, and P. H. Fishman. 1979. Ganglioside in- 
hibition of fibronectin-mediated cell adhesion to collagen. Proc.  Natl. 
Acad. Sci.  USA.  76:3367-3371. 
29. Klier, F. G., D. Schubert, and S. Heinemann. 1977.  The ultrastructural 
differentiation  of the clonal myogenic cell line L6 in normal and high K + 
medium. Dev. Biol.  57:440-449. 
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly 
of the head of bacteriophage T4. Nature (Lond,).  277:680-685. 
31, Lark, M. W., and L. A. Cuip. 1981. Turnover ofbeparan sulfate proteogly- 
cans from substratum  adhesion sites ofmurine fibrobiasts. J. Biol.  Chem. 
259:6773-6782. 
32. Mugnai, G., D. Tombaecini, and S. Ruggieri. 1984. Ganglioside composi- 
tion of substrate-adhesion  sites of normal and vitally-transformed  BalblC 
3T3 cells. Biochem.  Biophys.  Res.  Commun.  125:142-148. 
33. Nieolson, G. L. 1984. Cell surface molecules and tumor metastasis. Regu- 
lation of metastatic phenotypic diversity. Exp.  Cell Res.  150:3-22. 
34. Okada, Y., G. Mognai, E. G. Bremer, and S. Hakomori.  1984.  Glyco- 
sphingolipids in detergent-insoluble  substrate attacturtent matrix (DISAM) 
prepared from substrate attachment material (SAM): their possible role 
in regulating cell adhesion. Exp.  Cell Res.  155:448-456. 
35. Parker, P. J., S. Young, W. J. Gullick, E. L. V. Mayes, P. Bennett, and 
M.  D.  Waterfield.  1984.  Monoclonal  antibodies against the human 
epidermal growth factor receptor from A431 cells. J. Biol.  Chem.  259: 
9906-9912. 
36. Perkins, R. M., S. Kellie,  B. Patel, and D. R. Critehley.  1982.  Ganglio- 
sides as receptors for fibronectin.  F_ap. Cell Res.  141:231-243. 
37, Pierschbacher, M. D., and E. Ruoslahti. 1984. Cell attachment activity of 
fibronectin can be duplicated by small synthetic fragments of the mole- 
cule. Nature (Lond.).  309:30-33. 
38. Plow, E~ F., M. D. Pierschbacher, E. Ruoslahti, G. A. Marguerie, and 
M. H. Ginsberg.  1985. The effect of Arg-Gly-Asp-containing  peptides 
on fibrinogen and yon Willebrand factor binding to platelets. Proc. Natl. 
Acad. Sci.  USA.  82:8057-8061. 
39. Pytela, R., M. D. Pierschhacher, S. Argraves, S. Suzuki, and E. Ruoslahti. 
1987.  Arg-Gly-Asp adhesion receptors. Methods Enzymol. In press. 
40. Pytela, R., M. D. Pierschbacher, M. H. Ginsburg, E. Plow, and E. Ruos- 
lahti. 1986. Platelet membrane glyeoprotein l~/Illa member of a family 
of Arg-Gly-Asp-speeific adhesion receptors. Science (Wash.  DC). 231: 
1559-1562. 
41. Pytela, R., M. D. Pierschbacher, and E. Ruoslahti. 1985. Identification and 
isolation of a  140 Kd cell surface glycoprotein with properties expected 
of a fibronectin receptor.  Cell.  40:191-198. 
42. Pytela, R., M. D. Pierschbacber, and E. Ruoslahti. 1985. A 125/115-kDa 
cell  surface receptor specific  for vitronectin interacts with the arginine 
glycine-aspartic acid adhesion sequence derived from fibronectin.  Proc. 
Natl, Acad.  Sci.  USA. 82:5766-5770. 
43. Ruoslahti, E., and M. D. Pierschbacher. 1986.  Arg-Gly-Asp: a versatile 
cell recognition signal. Cell. 44:517-518. 
44. Schulz, G., D. A. Cheresh, N. M. Varki, A. Yu, L. K. Staffileno,  and 
R. A. Reisfeld. 1984. A murine monoclonal antibody detects ganglioside 
GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res. 
44:5914-5920. 
45. Sharom, F. J., and C. W. M. Grant.  1978.  A model for ganglioside be- 
havior in cell membranes. Biochim. Biophys.  Acta. 507:280-293. 
46. Slot, J.  W., and H. J. Geuze.  1981.  Sizing of protein A-colloidal gold 
probes for irnmunoelectron microscopy. ,,I. Cell Biol.  90:533-536. 
47. Spiegel, S., J.  Schlessinger, and P. H. Fishman. 1984.  Incoporation of 
fluorescent  gangliosides into human fibroblasts:  mobility, fate, and inter- 
action with fibronectin.  J.  Cell Biol.  99:699-704, 
48. Springer, W. R., P. L. Haywood, and S. H. Barondes. 1984.  Discoidin I 
is implicated in cell-substratum  attachment and ordered cell migration of 
Dietyostelium discoideum and resembles fibronectin.  Cell. 39:557-564. 
49. Suzuki, S., W. S. Argraves, R. Pytela, H. Arai, T. Krusius, M. D. Piersch- 
baeher, and E. Ruoslahti. 1986. eDNA and amino acid sequences of the 
cell adhesion receptor recognizing vitronectin reveal a transmembrane 
domain and homologies  with other adhesion receptors. Proc. Natl. Acad. 
Sci.  USA.  83:8614-8618. 
50. Svennerholm, L.  1963. Chromatographic separation of human brain gan- 
gtiosides. Neurochemistry.  10:613-623. 
51. Symington, F. W., I. D. Bernstein, and S. I. Hakomori. 1984. Monoclonal 
antibody specific  for lactosylceramide. J. Biol.  Chem.  259:6008-6012. 
52. Thompson, L. K., P. M. Horowitz, K. L. Bentley, D. D. Thomas, J. F. 
Alderete, and R. J. Klebe. 1986. Localization of the ganglioside-binding 
site of fibronectin.  J.  Biol.  Chem.  261:5209-5214. 
53. Yamada, K. M., D. W. Kennedy, G. R. Grotendorst, and T. Momoi. 1981. 
Glycolipids:  receptors for fibronectin?  J.  Cell Physiol.  109:343-351. 
Cheresh et al. GD2 and Cations/Glycoprotein Adhesion Receptor  1173 